Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Non-Alcoholic Steatohepatitis (FLIRT)
NCT00492700Phase 2Completed
- Sponsor
- Association pour la Recherche sur les Maladies Hépatiques Virales
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Nonalcoholic steatohepatitis (NASH) comparing Rosiglitazone with Placebo (2 arms). Primary endpoint: Improvement of at least 30% of the histological score of steatosis at 1 year. Started Jan 2003; status: completed.
02
Drugs
rosiglitazone
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00492700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492700.